GW Pharma Exceeds Expectations with $108 Million Preliminary Unaudited Revenue in 4th Quarter

New Cannabis Ventures
By NCV NewswireJan 12, 2020, 6:29 pm268 pts
GW Pharmaceuticals Pre-Announces Preliminary Unaudited Fourth Quarter and Full-Year 2019 Net Product Sales Total preliminary net product sales of approximately $108 million for the fourth quarter and approximately $309 million for the full year Total Epidiolex® preliminary net product sales of approximately…

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

Senate Committee Pushes VA To Explore Medical Marijuana As An Opioid Alternative For Veterans 74

Cannabis culture hits a high note using music as a marketing tool 69

California Governor He’s ‘All In’ On Psychedelic Therapy Access, But Worries About Capitalists Commercializing It 68

Cresco Labs Exiting California Cannabis Market 66

US government contradicts itself on weed – here’s why it matters 59

Alberta now permits cannabis sales at events where minors are present 55

Researchers in Brazil Discover CBD in Tropical Shrub 55

Minnesota Town Asks Residents to Help Name City-Branded THC Gummy 54

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.